tiprankstipranks
IO Biotech (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Technical Analysis

Compare
322 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
IO Biotech’s (IOBT) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting IO Biotech is a Sell.
IO Biotech’s (IOBT) 20-Day exponential moving average is 0.96, while IO Biotech’s (IOBT) share price is $1.1, making it a Buy.
IO Biotech’s (IOBT) 50-Day exponential moving average is 0.94, while IO Biotech’s (IOBT) share price is $1.1, making it a Buy.

IO Biotech (IOBT) Pivot Points

Feb 23, 2025, 12:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.82
0.89
1.00
1.07
1.18
1.24
1.35
Fibonacci
0.89
0.96
1.00
1.07
1.14
1.18
1.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

IO Biotech (IOBT) Moving Averages

Feb 23, 2025, 12:36 AM
Period
Simple
Exponential
MA5
1.02Buy
1.04Buy
MA10
0.98Buy
1.00Buy
MA20
0.96Buy
0.96Buy
MA50
0.90Buy
0.94Buy
MA100
0.97Buy
0.99Buy
MA200
1.13Sell
1.15Sell
IO Biotech’s (IOBT) 10-Day exponential moving average is 1.00, while IO Biotech’s (IOBT) share price is $1.1, making it a Buy.
IO Biotech’s (IOBT) 100-Day exponential moving average is 0.99, while IO Biotech’s (IOBT) share price is $1.1, making it a Buy.
IO Biotech’s (IOBT) stock price is $1.1 and IO Biotech’s (IOBT) 50-day simple moving average is 0.90, creating a Buy signal.
IO Biotech’s (IOBT) stock price is $1.1 and IO Biotech’s (IOBT) 100-day simple moving average is 0.97, creating a Buy signal.
IO Biotech’s (IOBT) stock price is $1.1 and IO Biotech’s (IOBT) 200-day simple moving average is 1.13, creating a Sell signal.

IO Biotech (IOBT) Technical Indicators

Feb 23, 2025, 12:36 AM
Name
Value
Implied Action
RSI (14)
68.77
Neutral
STOCH (9,6)
91.84
Sell
STOCHRSI (14)
92.67
Sell
MACD (12,26)
0.04
Sell
ADX (14)
26.99
Neutral
Williams %R
-12.82
Sell
CCI (14)
234.48
Sell
ATR (14)
0.07
-
Ultimate Oscillator
77.18
Buy
ROC
22.22
Buy
IO Biotech’s (IOBT) Relative Strength Index (RSI) is 68.77, creating a Neutral signal.
IO Biotech’s (IOBT) Trend Strength Indicator (ADX) is 26.99, creating a Neutral signal.
IO Biotech’s (IOBT) Commodity Channel Index (CCI) is 234.48, creating a Sell signal.
IO Biotech’s (IOBT) Price Rate of Change (ROC) is 22.22, creating a Buy signal.

FAQ

Is IOBT a Buy, Hold, or Sell?
Based on IOBT’s technical indicators, IOBT is a Buy.
    What is IOBT’s RSI (14)?
    IOBT’s RSI (14) is 68.77, which suggests IOBT is a Neutral.
      What is IOBT’s MACD?
      IOBT’s MACD is 0.04, which suggests IOBT is a Sell.
        What is IOBT’s 5-day moving average?
        IOBT’s 5-day moving average is 1.02, which suggests IOBT is a Buy.
          What is IOBT’s 20-day moving average?
          IOBT 20-day moving average is 0.96, which suggests IOBT is a Buy.
            What is IOBT’s 50-day moving average?
            IOBT’s 50-day moving average is 0.90, which suggests IOBT is a Buy.
              What is IOBT’s 200-day moving average?
              IOBT’s 200-day moving average is 1.13, which suggests IOBT is a Sell.
                What is IOBT’s Williams % R (14)?
                IOBT’s Williams % R (14) is -12.82, which suggests IOBT is a Sell.
                  What is IOBT’s CCI (14)?
                  IOBT’s CCI (14) is 234.48, which suggests IOBT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis